Treatment of Non-Aspergillus Moulds in Immunocompromised Patients, with Amphotericin B Lipid Complex
Open Access
- 1 May 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (Supplement) , S401-S408
- https://doi.org/10.1086/429331
Abstract
An assessment was made of the efficacy and renal safety of amphotericin B lipid complex (ABLC) in the treatment of patients with invasive fungal infeKeywords
This publication has 37 references indexed in Scilit:
- Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatusJournal of Clinical Microbiology, 2004
- Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving VoriconazoleClinical Infectious Diseases, 2004
- Invasive Zygomycosis in Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole ProphylaxisClinical Infectious Diseases, 2004
- Fusarium Infection in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2004
- Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell TransplantsNew England Journal of Medicine, 2004
- Infections due to emerging and uncommon medically important fungal pathogensClinical Microbiology & Infection, 2004
- Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp.Clinical Microbiology & Infection, 2004
- Changing patterns of fungal infection in transplantationCurrent Opinion in Organ Transplantation, 2000
- RECENT PROGRESS AND CURRENT PROBLEMS IN TREATMENT OF INVASIVE FUNGAL INFECTIONS IN NEUTROPENIC PATIENTSInfectious Disease Clinics of North America, 1996
- Blastomycosis in Transplant Recipients: Report of a Case and ReviewClinical Infectious Diseases, 1993